Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

Integra Lifesciences Holdings (IART) Equity Ratio (2009 - 2026)

Integra Lifesciences Holdings recorded quarterly Equity Ratio of 0.29 in Q1 2026, up 0.58% quarter-over-quarter from 0.29 in Q4 2025, and down 22.53% year-over-year from 0.38 in Q1 2025.

Integra Lifesciences Holdings' Equity Ratio history runs 18 years deep, the most recent figure standing at 0.29 for Q1 2026.

  • In Q1 2026, Equity Ratio fell 22.53% year-over-year to 0.29; the TTM figure through Mar 2026 stood at 0.29 (down 22.53% YoY), while the FY2025 annual figure was 0.29, down 24.31% from the prior year.
  • Equity Ratio came in at 0.29 for Q1 2026 at Integra Lifesciences Holdings, up from 0.29 in the prior quarter.
  • In the past five years, Equity Ratio ranged from a high of 0.46 in Q4 2022 to a low of 0.28 in Q2 2025.
  • A 5-year average of 0.39 and a median of 0.39 in 2024 frame the typical range for Equity Ratio.
  • Across the five-year window, Equity Ratio increased 7.62% in 2022 and decreased 24.79% in 2025, its largest moves.
  • Integra Lifesciences Holdings' Equity Ratio stood at 0.46 in 2022, then slipped by 9.49% to 0.42 in 2023, then declined by 8.84% to 0.38 in 2024, then dropped by 24.31% to 0.29 in 2025, then gained by 0.58% to 0.29 in 2026.
  • According to Business Quant data, Equity Ratio over the past three periods registered 0.29, 0.29, and 0.28 for Q1 2026, Q4 2025, and Q3 2025 respectively.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Equity Ratio (Qtr)
1 Abbott Laboratories 152.82 Bn 146.17 Bn 6.27 Bn 0.47
2 Stryker 115.07 Bn 112.19 Bn 3.81 Bn 0.50
3 Medtronic 95.25 Bn 87.08 Bn 5.76 Bn 0.54
4 Boston Scientific 71.38 Bn 70.17 Bn 3.61 Bn 0.59
5 Edwards Lifesciences 51.08 Bn 47.41 Bn 1.29 Bn 0.78
6 Koninklijke Philips 29.38 Bn 26.07 Bn 2.07 Bn -
7 Dexcom 28.84 Bn 27.72 Bn 750.30 Mn 0.45
8 GE HealthCare Technologies 28.56 Bn 26.49 Bn 1.98 Bn 0.29
9 Steris 20.71 Bn 20.30 Bn 697.10 Mn 0.67
10 Integra Lifesciences Holdings 1.20 Bn 939.16 Mn 216.98 Mn 0.29

Historic Data

Download Data 🔒
DateValue
Mar 31, 2026 0.29
Dec 31, 2025 0.29
Sep 30, 2025 0.28
Jun 30, 2025 0.28
Mar 31, 2025 0.38
Dec 31, 2024 0.38
Sep 30, 2024 0.37
Jun 30, 2024 0.38
Mar 31, 2024 0.39
Dec 31, 2023 0.42
Sep 30, 2023 0.42
Jun 30, 2023 0.45
Mar 31, 2023 0.45
Dec 31, 2022 0.46
Sep 30, 2022 0.45
Jun 30, 2022 0.44
Mar 31, 2022 0.44
Dec 31, 2021 0.45
Sep 30, 2021 0.43
Jun 30, 2021 0.42
Mar 31, 2021 0.41
Dec 31, 2020 0.42
Sep 30, 2020 0.40
Jun 30, 2020 0.40
Mar 31, 2020 0.39
Dec 31, 2019 0.43
Sep 30, 2019 0.41
Jun 30, 2019 0.43
Mar 31, 2019 0.44
Dec 31, 2018 0.44
Sep 30, 2018 0.43
Jun 30, 2018 0.42
Mar 31, 2018 0.31
Dec 31, 2017 0.30
Sep 30, 2017 0.38
Jun 30, 2017 0.43
Mar 31, 2017 0.42
Dec 31, 2016 0.46
Sep 30, 2016 0.45
Jun 30, 2016 0.44
Mar 31, 2016 0.42
Dec 31, 2015 0.42
Sep 30, 2015 0.40
Jun 30, 2015 0.43
Mar 31, 2015 0.44
Dec 31, 2014 0.44
Sep 30, 2014 0.44
Jun 30, 2014 0.44
Mar 31, 2014 0.44
Dec 31, 2013 0.56
Sep 30, 2013 0.42
Jun 30, 2013 0.44
Mar 31, 2013 0.44
Dec 31, 2012 0.44
Sep 30, 2012 0.44
Jun 30, 2012 0.44
Mar 31, 2012 0.44
Dec 31, 2011 0.43
Sep 30, 2011 0.43
Jun 30, 2011 0.45
Mar 31, 2011 0.52
Dec 31, 2010 0.49
Sep 30, 2010 0.49
Jun 30, 2010 0.49
Dec 31, 2009 0.47